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Executive Summary 
  A previous study, EQUIP 2009, found the rate of in-hospital prescription errors in 19 
hospitals across Manchester, England, to be nearly nine percent. Prescription errors have been 
shown to contribute to adverse drug events, prolonged hospital stay, increased morbidity and 
mortality, and increased cost. The aim of this pilot study is to determine if constructive feedback 
by consultants (senior physicians) to junior physicians on their prescribing errors changes their 
attitudes toward prescribing safety. The hope is that feedback sessions will help solidify a deeper 
understanding of both the situation and individual actions on errors and more effectively impact 
future actions.  
  The study was conducted in July 2012 with 9 junior physicians, graduate doctors in 
training, from Wythenshawe Hospital, England. Two of the nine originally identified physicians 
were unable to participate in feedback due to one having a conflict of schedule and the other 
leaving the hospital. A questionnaire was given to junior physicians before and after the 
feedback session to identify attitudes toward prescribing errors. I used discharge prescriptions 
before and after feedback to determine the prescribing error rate and severity of errors; a senior 
physician from the ward provided the feedback within two weeks. The Hewson and Little’s 
Feedback Model was used as a guide for the sessions to ensure non-threatening and objective 
feedback. Outcome measures include changes in error prevalence, attitudes before and after, and 
evaluating the usefulness of feedback as a learning tool. Analysis includes descriptive statistics 
and Fisher’s exact tests on data collected from survey response and medication discharge lists. 
 There was a 71% response rate to all three surveys (pre-intervention, post-intervention, 
and feedback). Survey responses revealed that physicians felt they had made fewer errors after 
receiving feedback. Analysis of discharge medication lists of all nine physicians showed a 
decrease in rate of prescribing errors from pre- to post-intervention (15.5% and 13.5% 
respectively). Following elimination of the two physicians excluded from feedback, the 
difference in rate of prescribing errors was greater between pre- and post-intervention (17% and 
10.2% respectively).  
 The majority of physicians did not feel this experience altered their ways of prescribing. 
However, all physicians who provided responses to the feedback survey questionnaire indicated 
that they were happy with pharmacy collecting information about their prescribing errors. They 
were not pleased that consultant physicians instead of pharmacists conveyed these errors to them. 
Four out of the five physicians said they would recommend this program to their colleagues. 
Physicians also expressed the desire for more of their discharge medication lists to be evaluated 
and on a more frequent basis.  
 Results of this study show that the use of feedback sessions was widely accepted by 
physicians. Future programs should consider pharmacists as the providers of feedback based on 
survey responses. 
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Introduction 
Background 
 Every year prescribing errors lead to adverse events. The 2009 EQUIP study found errors 
in 9% of prescriptions in 19 different hospitals.1 The importance of medication safety is stressed 
in educating healthcare workers. Reducing and ultimately eliminating prescribing errors is 
essential in ensuring patient safety as well as affordable healthcare in the current economic state. 
 In promoting safety, it is thought that the right attitude is just as important as skill and 
knowledge.2 Altering attitudes may lead to improved safety within an institution (hospital). 
Studies often focus on level of knowledge, leaving out evaluation of individual attitudes. The 
EQUIP study evaluated the errors prescribers had made but they were not notified of these errors 
were not enabled to learn from them.  
 Feedback is often used to identify deficiencies in what is being done and what is 
expected. Utilizing a prescriber’s errors to construct feedback may help improve prescribing 
safety by reducing prescribing errors. Previous studies exploring the provision of feedback to 
influence prescribing safety have been done in the primary care or outpatient setting but little has 
been done inpatient.3,4 
 This study has chosen to focus on physicians in training. In the United Kingdom, first and 
second year physicians are required to keep professional development portfolios which help 
them to reflect on their learning experience. This process is similar to the training medical 
residents receive in the United States. Incidents of patient safety are recorded in the portfolio’s 
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“Safe Prescribing” section for determining competency. Each physician should have personal 
interest in ensuring they use this experience for improvement to demonstrate competency. 
 The more senior physicians (consultant physicians) at Wythenshaw Hospital proposed 
incorporating prescribing error feedback sessions as part of initial hospital training of new 
physicians. These sessions are designed to provide non-threatening and constructive feedback on 
errors that have been identified on physician’s discharge medication lists. This project aims to 
evaluate the effect that the feedback sessions have on prescribing errors as well as the 
physician’s attitudes towards prescribing safety. 
Literature Review 
Overview 
 The literature review focuses on the prevalence of prescribing errors. It also focuses on 
potential causes or trends that lead to prescribing errors and methods for elimination. 
Literature Review 
The Institute of Medicine (IOM) report from 1999, To Err Is Human: Building a Safer 
Health System, was written to convey the impact that medical errors have on society. This work 
made the conclusion that, “more people die in a given year as a result of medical errors than 
from motor vehicle accidents, breast cancer, or AIDS.”5 This conclusion was based on two large 
studies, one conducted in the state of New York, the other in the states of Utah and Colorado.6-7 
Retrospective review of patient files revealed rates of adverse events, “injuries caused by 
medical management,”6 to be 3.7 and 2.9 percent, respectively. The IOM report used these 
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percentages to conclude that, out of the 33.6 million hospital admissions in the U.S. in 1997, at 
least 44,000 to 98,000 people die each year due to medical errors such as prescribing errors.5 
Much controversy arose over the report’s claim about the number of individuals that die 
due to medical error. Leape8 wrote an article entitled, Institute of Medicine Medical Error 
Figures Are Not Exaggerated, responding to the stimulus that the IOM report created. The article 
posed three main reasons to prove the report did not exaggerate. First, Leape argues that the two 
studies, on which the conclusion is based, undoubtedly missed some errors but could not have 
found errors that did not exist, suggesting underestimation of the number of adverse events. 
Second, the studies only reported on errors made in-hospital and do not include things such as 
outpatient surgery procedures, where errors could be made. Last, record-review studies have 
been shown to underestimate results when compared to prospectively performed studies. 
The focus of studies has since been redirected from the existence of error, to the source of 
error and methods for elimination. Winterstein et al.9, performed an analysis in a large specialty 
care hospital to determine patterns and causes of medication-related medical errors. Of the 240 
medication error reports included in analysis, 95 were manifested errors and the remainders were 
classified as near misses, meaning the error was caught before it reached the patient. The 
majority of medication errors originated during prescribing (72%) and were linked to knowledge 
deficits in pharmacotherapy (39%) or failure to review critical patient information (18%). The 
manifestations of these errors most commonly were uncontrolled infection due to under-dosing 
of antiinfectives therapy (23%), renal failure due to overdosing of antiinfectives (4%), central-
nervous-system intoxication due to overdosing (4%), or poor pain control due to underdosing 
(4%).  
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Prescribing errors have been reported to affect up to 50% of hospital admissions and 7% 
of medication orders.10 Recent studies found that 9-15% of hospital medication orders in the UK 
contained one or more prescribing errors. 11 In the U.S., studies have shown a high prevalence of 
prescribing errors made upon hospital admission, with greater than one-third of 651 patients 
affected.12  
 The EQUIP Study1 was aimed at exploring the causes of prescribing errors, focusing on 
first year physicians. This study suggests that first year physicians are twice as likely to make 
prescribing errors than a more senior physician. 
 Inspired by the findings of the EQUIP Study, Seden et al.14, conducted a “Cross-sectional 
study of prescribing errors in patients admitted to nine hospitals across North West England.” 
The study was designed to produce data on “factors which may contribute to prescribing errors,” 
such as admission or discharge order status, the prescribers’ level of training, or type of 
medication. One or more errors were observed in 1,857 (43.8%) of the 4,238 prescriptions 
evaluated. Errors were rated using a severity scale with four levels: minor, significant, serious, or 
potentially lethal error established in the EQUIP Study (Appendix 6). Of the 3,011 errors 
observed, 1264 (41.9%) were minor, 1629 (54.1%) were significant, 109 (3.6%) were serious, 
and 9 (0.3%) were potentially lethal. Rates of prescribing errors were not significantly different 
between first year physicians and middle or senior physicians. The study found that the strongest 
contributing factor for a prescribing error being made was the number of items on a prescription. 
This was found to be a linear relationship; for each additional item included on the prescription, 
risk of error increased by 14% (OR 1.14, 95% CI 1.12 to 1.17, p<0.001).  
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 Studies have considered educational feedback session as a means to eliminate prescribing 
errors. Eisenhut et al.15 evaluated the use of feedback targeted at prescribers as a means to reduce 
prescribing errors in pediatric patients. Sixteen physicians were selected to receive written 
assessment of their prescribing skills. The physicians then received feedback based on their 
performance. Audit of the intervention showed a decrease in errors from 47 to 21 and a decrease 
in the number of patients affected from 19 to 11 per 100 emergency admissions (p=0.001). 
Summary of Literature Review 
 Prescribing errors have the potential to negatively impact patient care. The Institute of 
Medicine report in 1999 stimulated a focus on patient safety by shocking the public with the 
conclusion that 44,000 to 98,000 people die each year due to medical errors.  Medical error can 
translate to mean a variety of different things. This review focuses specifically on medication-
related medical errors.  
 The majority of medication errors originate during the initial prescribing of a medication. 
These prescribing errors can be associated with a lack of pharmacotherapy knowledge. Several 
factors have been considered to contribute to an increase in prescribing errors made including: 
level of training, ward or unit location within a hospital, whether a medication is ordered at 
admission or discharge, and number of items on an order or prescription. 
 Often first year physicians are considered to have a lower level of knowledge than more 
senior physicians. Studies have found that these new lower level physicians are twice as likely to 
make a prescribing error. Targeted feedback is one method studied in attempts to improve 
prescribing practices and resulted in a decrease in number of prescribing errors. 
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Methodology 
Research Design 
 I conducted this project in Manchester, England at Wythenshawe Hospital in Manchester, 
England. It can be divided into four parts. The first part is the collection of data on physicians’ 
attitudes towards prescribing errors. Survey questionnaires were utilized to obtain data for the 
first part of the project. This was done both before and after they were provided with feedback. 
The second part is an analysis of patient discharge medication lists for prescribing errors. The 
discharge medication lists were obtained through the pharmacy computer system. The third part 
is the provision of individualized feedback to prescribers. This was done by one of two trained 
physicians using the Hewson and Little Feedback Model (Appendix 5). The final part of the 
project was obtaining feedback about the process from the participating prescribers. This was 
done through survey questionnaires.  
 For all parts of the project, 9 physicians were identified as “qualified” participants. In 
order to be qualified for the study participants had to be in their first or second year of practice 
after the completion of medical school. Quantitative data (Part 2) was collected for all nine 
physicians. Two of the physicians were unable to participate in feedback because one left the 
hospital and the other had conflicts while working the night shift schedule, therefore feedback 
sessions were conducted for only seven of the nine originally identified physicians. Of the seven 
physicians who received feedback, only five physicians chose to provide responses to the survey 
questionnaires. 
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Part 1: Identifying Physicians’ Attitudes Towards Prescribing Errors 
 The prescribing attitudes survey is designed to identify opinions on topics such as the 
number of errors they believe they have made (in the past week), what they believe constitutes a 
prescribing error, how they know when a prescription is safe, and other questions of relevance 
(Appendix 2). The survey was administered to each participating prescriber both before and after 
they received feedback. I mailed surveys for both phases to prescribers with instructions to 
complete and mail back using the pre-paid, addressed envelopes provided in addition to the 
survey. Prescribers were asked to identify their level of training (job title) and their gender. To 
maintain anonymity names were not included in aggregated data sets.  
Part 2: Evaluation of Discharge Medication Lists for Prescribing Errors 
 I performed an audit to evaluate discharge medication lists prepared by participating 
prescribers for prescribing errors. I obtained discharge medication lists prepared by each 
participant through hospital record and evaluated them for prescribing errors. Prescribing errors 
were identified as one out of thirty possible error types (Appendix 4; Table 1). Errors that were 
identified were then classified into severity types: minor, significant, serious or potentially fatal 
(Appendix 6). The error severity scale was meant to be used as a tool in aiding classification. To 
determine severity, patient specific characteristic were looked at such as weight and renal 
(kidney) function to determine if something should be classified as an overdose. For each error, 
the class of the medication was determined and counts of errors per medication class were 
recorded.  
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 This process was done using both discharge medication lists prepared by prescribers 
before receiving feedback and after receiving feedback. Errors that were found on discharge 
medication lists in the before time period were used to target feedback based on the individual.  
 
Part 3: Providing Prescribers with Feedback 
 Prescribers, prior to receiving feedback, were given copies of discharge medication lists 
that they had written containing errors. They were given the opportunity to use these to reflect 
prior to meeting with a supervising physician (consultant physician). Each participating 
prescriber was scheduled for a feedback session with one of two trained supervising physicians. 
The two physicians providing feedback were instructed to make feedback be non-threatening, 
non-judgmental and objective (Appendix 1). The approach is meant to create a greater 
understanding of both the self and situation so that future actions can be informed by 
understanding. The Hewson and Little Feedback Model (Appendix 5) was used to structure 
feedback sessions. Consultants tailored feedback sessions based on the errors found on each 
prescriber’s discharge medication lists. 
Part 4: Prescribers Provide Feedback  
In addition to the pre- and post-feedback surveys, prescribers were asked to complete a 
feedback survey (Appendix 3) evaluating the usefulness of participating in the project. 
Prescribers were asked to disclose information such as what they liked most about the 
experience, what they liked least, and if they felt the experience changed their prescribing 
practices. As this is a pilot study, it was important to gain feedback from the physicians who 
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participated as to whether they believed the provision of feedback was beneficial to their 
prescribing practices and whether they would recommend others to participate. 
 Descriptive statistics were used to summarize the data collected from the questionnaires. 
Categorical measures were described with counts and percentages. Comparisons between 
categorical variables were made with chi-square tests or Fisher’s exact, when warranted by small 
cell count.   
 Comparisons of quantitative data collected from medication discharge errors were 
evaluated using descriptive statistics. Analysis looked for trends in the number of prescribing 
errors made pre- and post-intervention. 
Results 
Characteristics of Patient and Prescriber Population 
The study included 48 persons with discharge medication summaries that were created by 
nine different junior physicians. Patient age ranged from 23 to 96 years, with a mean age of 73. 
The average number of medications per patient was 8, ranging from 1 to 20 (Table 1). 
Table 1: Demographics of Patients at the Time That the Discharge 
Medication Orders Were Created 
 Age (years) Number of 
Medications 
Range 23 to 96 1 to 20 
Average 73 8 
 
Of the nine junior physicians identified for the study, two were unavailable for survey 
response; one left the South Manchester Foundation Trust and one had scheduling conflicts due 
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to working night shift. Out of the seven physicians sent surveys, only five responses were 
received for each of the three surveys (71% response rate). Responders were primarily male 
(60%) and foundation year two (FY2) physicians for the pre-intervention (40%), post-
intervention (60%), and feedback (60%) surveys. Only one physician submitted both the pre- and 
post-intervention surveys (Table 2). 
Table 2: Demographics of Physicians at the Time of Response to the Surveys 
 Pre-Intervention Post-Intervention Feedback 
Male Sex 3 out of 5 3 out of 5 3 out of 5 
First Year 
Physician (FY1)/ 
Core Trainee Year 
1 (CT1) 
1 out of 5 2 out of 5 2 out of 5 
Foundation Year 2 2 out of 5 3 out of 5 3 out of 5 
Specialist Trainee 
Year 2 (ST2) 
2 out of 5 0 out of 5 0 out of 5 
 
Attitudes Towards Prescribing Errors 
Physicians were asked to respond to the same eleven questions on both the Pre- and Post-
Intervention surveys. The first three questions asked physicians how often they perceived they 
made a prescribing error, then asked how many errors made were minor and how many were 
serious. On average, physicians felt they made fewer errors post-intervention (1.4 errors) than 
pre-intervention (3 errors). The decrease in errors was seen more in the minor prescribing error 
category. Few felt that the intervention had a significant impact on the number of severe errors 
that were made. The majority of physicians reported that a pharmacist was the most likely 
individual to point out whether a prescribing error had been made (Table 3). 
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Table 3: Physician Responses to Pre- and Post-Intervention Survey Questions on Frequency of Prescribing 
Errors Made, Who Points out Errors, and What Physicians Believe Constitutes a Prescribing Error 
 Pre-
Intervention 
Post-
Intervention 
How many prescribing errors do you think you made in the past 
week? (average) 
3 1.4 
How many minor errors were made in the past week? (average) 2.2 1.2 
How many serious errors were made in the past week? (average)  0.4 0.4 
Who was the last person to point out a prescribing error you made? 
(%) 
 
Pharmacist  100 60 
Noticed Myself 0 20 
Pharmacist/Nurse 0 20 
What constitutes a prescribing error? (%)  
Overdose 80 80 
Under-dose 80 80 
Incorrect route 80 80 
Omitted dose 60 80 
Omitted route 40 80 
Omission of a medication on admission 20 60 
Omission of a medication during patient stay 20 60 
Omission of a medication on discharge 60 60 
Premature discontinuation of a drug 80 60 
Drug not prescribed but indicated 60 60 
Continuation of drug for longer than needed 100 80 
No indication for drug 40 40 
Significant known allergy 80 80 
Clinical contra-indication 80 80 
Duplication of therapy 80 80 
Drug interaction 80 60 
No maximum dose 20 40 
Dose/rate mismatch 80 80 
No dosage alteration after levels out of range 60 80 
Incorrect formulation 80 80 
Administration times incorrect 80 80 
Administration times missing 60 80 
Start date incorrect 40 40 
Start date missing 40 60 
Product/formulation not specified 60 40 
Strength/dose missing 80 80 
No signature 80 80 
Requirements for controlled drug prescriptions incorrect 80 80 
Requirements for controlled drug prescriptions missing 80 80 
Prescribing a branded medication 20 20 
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Out of a list of thirty items (Appendix 2, Question 5), 16 items on the Pre-Intervention 
Survey were determined by four out of five (80%) physicians to constitute a prescribing error. 
Post-intervention, 18 items were acknowledged by four out of five as prescribing errors. A total 
of eight items had an increase in the number of physicians that recognized them as prescribing 
errors: omission of a medication on admission, omission of a medication during patient stay, 
omitted route, no maximum dose, start date missing, omitted dose, no dosage alteration after 
levels out of range, and administration times missing. The two items that received the largest 
increase in recognition from pre-intervention to post-intervention were: omission of a medication 
on admission and omission of a medication during patient stay (3-fold increase; 20% vs. 60%). 
All of the physicians felt that they made fewer errors at the time of the surveys than at the 
start of their career. Most believed that prescribing was no less important than diagnosing and the 
majority (60%) agreed prescribing was a complex task. When asked about the physician’s 
responsibility for identifying prescribing errors, all wanted to know about any serious errors 
made and agreed that the ward pharmacist should point out these errors. Fisher’s exact tests were 
used to compare the Pre-Intervention and Post-Intervention responses between Agree/Strongly 
Agree and Disagree/Strongly Disagree. No significant difference was found. 
Preparedness of Prescribers 
To determine the measures physicians use to ensure the accuracy and completeness of 
prescriptions, they were asked questions on the resources and practices used when prescribing. 
Questions asked how often physicians used certain resources and whether they gathered 
information about side effects, allergies, and patient co-morbidities prior to writing a 
prescription. No significant differences were found from pre- to post-intervention between those 
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who reported using certain prescribing measures either always, most often, or often versus those 
who reported using these measures rarely or never. Although not significant, physicians did 
report conveying details of prescribing decisions with other members of the team more 
frequently in the post intervention survey than pre-intervention (Table 4). 
 
Resources that physicians reported using most often did not significantly change between 
pre- and post- intervention. Physicians report using the British National Formulary (no 
Table 4: Responses on Frequency of Prescribing Behaviors  
With what frequency do you 
demonstrate these behaviors 
when prescribing? (%) 
Pre-Intervention Post-Intervention 
 Always/ 
Most 
Always 
Often Rarely/ 
Never 
Always/ 
Most 
Always 
Often Rarely/ 
Never 
I have all the information I need 
about the drug I am prescribing 
including side effects and 
interactions 
60 40 0 60 40 0 
I make sure I have all the 
information I need about the 
patient including co-morbidities 
and allergies 
80 0 20 100 0 0 
I make sure I have taken an 
accurate drug history or have 
access to an accurate drug history 
80 20 0 80 20 0 
I check computerized alerts for 
interactions and allergies 
80 20 0 40 0 60 
I write prescriptions legibly with 
clear name and date 
80 0 20 100 0 0 
I actively check my prescriptions 
for errors before signing them 
100 0 0 100 0 0 
I follow up any prescribing that 
requires monitoring 
100 0 0 80 0 20 
I work with the pharmacist when 
prescribing 
80 20 0 40 40 20 
I convey details of my 
prescribing decisions to others in 
the team (either verbally or 
written) 
20 0 80 60 20 20 
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specification was made between text or electronic copies available via the internet), hospital 
formulary/guidelines, senior physicians, and pharmacists as resources used always or often when 
gathering information to ensure safe prescribing. Resources used only sometimes or never 
include: textbooks, websites (accredited and non-accredited), and nursing staff. 
Physicians were also asked what measures were taken to reduce the chance of making an 
error. Responses from both the pre- and post-intervention surveys were similar. The most 
common reported measure used to reduce error pre-intervention was to check prescribing using 
the British National Formulary (80% of responses). Responses post-intervention were varied and 
included checking patient’s current medical list, asking another member of the team, or simply 
double-checking the prescription. In order to determine the safety of the prescription, majority of 
physicians reported the approval of a pharmacist as the key measure for knowing if a 
prescription is written safely in both the pre-intervention (80%) and post-intervention (60%) 
periods.  
Differences in the Number of Prescribing Errors Made 
In addition to the survey data, information was also recorded using the discharge 
medication lists prepared by the nine physicians chosen for the study. Discharge medication lists 
were only available both before and after for four of the nine physicians due to lack of 
availability. Two out of the four physicians showed a decrease in the percentage of errors per 
drug item from before to after. One of the four physicians saw no change and the final physician 
had an increase in the number of errors made per drug item. On average, there was a decrease in 
the percentage of errors per item from before and after (Table 5). 
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Only seven out of the nine physicians were able to receive feedback. Physicians 105 and 
109 did not participate in receiving feedback. The difference in average number of errors per 
number of items before intervention (17%) and after intervention (10.2%) was much greater with 
the exclusions of physicians 105 and 109. Additionally, physician 107 had a large increase in the 
number of errors made from pre- (1 error) to post-intervention (9 errors). Exclusion of physicians 
105, 107, and 109 shows an 83% decrease in error rate from the pre- to post-intervention phase 
(18% and 3% respectively). 
Table 5: Prescribing Errors Made by Each Physician 
Physician 
Code 
Total 
Number of 
Errors 
Before 
Total 
Number of 
Errors 
After 
Total 
number of 
items 
(drugs) 
Before 
Total 
number of 
items 
(drugs) 
After 
Total 
Number of 
Errors 
Before/Tota
l Number of 
Items 
Before 
Total 
Number of 
Errors 
After/ Total 
Number of 
Items After 
101 2 - 15 - 13.3% - 
102 5 - 31 - 16.1% - 
103 5 2 28 54 17.9% 3.7% 
104 2 - 5 - 40.0% - 
105 1 - 19 - 5.3% - 
106 1 1 10 10 10.0% 10.0% 
107 1 9 9 35 11.1% 25.7% 
108 4 1 38 69 10.5% 1.4% 
109 - 11 - 41 - 26.8% 
Average 2.63 4.80 19.38 41.80 15.5% 13.5% 
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The data was also evaluated in terms of how many of each physician’s medication 
discharge lists contained at least one error. Out of all nine physicians, all had made at least a 
single error on a discharge list. Of the four physicians for which both before and after 
information was available for, three had decreases in the percentage of discharge lists that 
contained at least one error from before to after. Only one discharge list was available for the 
fourth physician for both the before and after periods and each contained at least one error. 
Errors made on the discharge lists were categorized into groups based on type, severity, 
and drug class. The four most prevalent error types were: underdosing of a medication (22.2%), 
omission of a medication from the discharge list (11.1%), continuation of a medication for longer 
than needed (11.1%), and incorrect formulation of a medication listed (11.1%). Other errors 
made included: administration times incorrect or missing (8.9%), lack of communication about a 
medication change (8.9%), overdose (6.7%), duplication of therapy (4.4%), unintentional 
prescription of drug (4.4%), incorrect route (4.4%), drug not prescribed but indicated (2.2%), no 
indication for drug (2.2%), and strength or dose missing (2.2%). 
Table 6: Severity of Errors Made on Medication Discharge Lists 
Potential 
Severity 
Rating 
Number 
of Errors 
(Total) 
Proportion 
of errors 
(%) 
Number 
of Errors 
(Before) 
Proportion 
of errors 
before (%) 
Number 
of Errors 
(After) 
Proportion 
of errors 
after (%) 
Minor 13 28.9% 4 19.0% 9 37.5% 
Significant 24 53.3% 15 71.4% 9 37.5% 
Serious 8 17.8% 2 9.5% 6 25.0% 
Potentially 
Fatal 0 0.0% 0 0.0% 0 0.0% 
Total 45  21  24  
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Errors made were most often classified as significant (53.3%). The remaining errors were 
either minor (28.9%) or serious (17.8%). None of the 45 errors found on the discharge lists were 
classified as potentially fatal (Table 6). A decrease was seen in the proportion of errors that were 
significant (71.4% to 37.5%) from the before to after period while increases were seen in the 
proportion of errors that were minor (19% to 37.5%) or serious (9.5% to 25%).  
Errors were categorized into 22 different drug classes (Appendix 7). The drug classes in 
which errors were made most frequently were antibacterial drugs (12.8%), analgesics (10.3%), 
antiepileptics (7.7%), and corticosteroids (7.7%).  
Feedback About the Intervention 
 
Four out of five physicians would recommend the experience to their colleagues. All 
physicians were happy with the pharmacist gathering data and relaying information to them 
about the errors they had made. The majority of physicians did not feel the experience changed 
their way of practice. The two physicians that did feel their current practices had changed both 
reported that the experience made them double check their prescribing. None of the physicians 
reported changing their practice by consulting advice from a pharmacist or another physician or 
using references when prescribing. Those who reported that the experience did not change their 
practice stated that they were only reassured of their good prescribing habits or felt that the errors 
found were insignificant. 
Although physicians felt the experience did not change their current practices, all were 
happy with the experience. Physicians reported that they most liked the reassurance that they 
were making few errors and the understanding on how to fix the errors that were being made. 
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What was least liked about the experience was that senior physicians were involved in telling 
them the errors they had made. 
Physicians were asked to rank out of registrars (in training to become a consultant), 
consultants (senior physicians), pharmacists, peers, and nurses the profession they would most 
prefer to deliver the feedback sessions. Averages of the responses led to the following order from 
most preferred to least: pharmacist, registrars, peers, nurses, and finally consultants. In addition 
to the preference to receive feedback from pharmacists, the physicians also felt that feedback 
should be provided on a more regular basis and that more of their discharge medication orders 
should be evaluated at a time. 
Discussion 
The survey results of this study produced some interesting findings. After receiving 
feedback, physicians felt that they had made fewer errors, they could recognize more items as 
being prescribing errors (Appendix 2, Question 5), and they were more likely to recognize an 
error themselves. 
In reviewing the numerical data collected from the discharge medication lists, there is a 
trend toward fewer errors post-intervention. The reduction seen is even greater if the physicians 
who did not participate in the feedback sessions are eliminated from analysis. This suggests that 
there is a benefit of using feedback intervention to reduce prescribing errors. 
More errors were found after the intervention most likely due to the review of more 
medication discharge lists in the after period than the before period. Results still show that, 
although an equal number of minor and significant errors were made in the after period, the 
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proportion of errors that were significant decreased while the proportion of minor errors 
increased. This suggests that after the intervention prescribers made only minor errors most 
often. The increase in the number of potentially serious errors in the after period could be 
explained by the review of more discharge lists in the after period. There was one physician 
(code 109) for which only after discharge lists were reviewed. This was the same physician who 
had the highest number of errors seen in either period. The inclusion of their discharge lists in the 
data had the potential to skew results.  
There was no pattern between the before and after period in terms of drug classes. 
Overall, errors were made more frequently with antibacterial drugs. Errors made with this class 
of drugs actually increased from the before to after period. The errors were categorized into a 
total of 22 drug classes. Of the 22 drug class categories, 11 of the classes saw an increase in the 
proportion of errors that were made in their class while the other 11 saw a decrease. An 
explanation for this being that feedback was given based on errors the physicians had made. If 
they had not made an error in the 11 classes where an increase was shown post-intervention, then 
they did not receive counseling on how to reduce these errors. 
The most important findings of this study were in the Feedback About the Intervention 
survey responses. Four out of five physicians would recommend the experience to their 
colleagues. Before initiating the study, there was concern about how the program would be 
perceived but all of survey responders agreed that they were happy with pharmacists collecting 
data about their prescribing errors. Responses further revealed that physicians would prefer for 
their errors to be conveyed to them by a pharmacist over other healthcare professionals. When 
asked to report what they liked the least about the experience, the majority stated that they did 
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not want their errors pointed out by consultants (senior physicians) that they have been working 
hard to impress. 
Limitations 
 Survey response rates were relatively high for all three surveys if calculated out of a total 
of seven physicians (71%). Actually response rates are lower (56%) if the two physicians that 
were lost to follow-up are included. The most important limitation to this study is small sample 
size due to the study being in a single center site. Evaluation at only one facility in the 
Manchester area limited the number of first and second year physicians available for 
participation to nine. Further elimination of two physicians due to scheduling conflicts, left only 
seven physicians who met the inclusion criteria. Due to inclusion of only first and second year 
physicians, results cannot be generalized to include all physicians.  
 A second limitation was inconsistency of survey response. Only one physician submitted 
all three surveys. The remaining responses were collected from different physicians, leaving 
open the question whether the responses are a true representation of the group. Feedback surveys 
were only obtained from physicians at the end of the study and are therefore more reliable.  
Conclusions and Implication 
 This study shows prescribing error rates as high as 15.5% (pre-intervention) in first and 
second year physicians at Wythenshawe Hospital. This rate is higher than the 9% rate found in 
the 2009 EUQIP Study1 suggesting that this may be an even larger problem at this one 
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institution, warranting further attention. These results cannot be extrapolated to include 
physicians at other institutions or physicians with higher levels of training. 
 From these results there is a trend toward a decrease in the number of prescribing errors 
made after receiving feedback intervention. Also of importance is that the physicians’ attitudes 
had changed and they felt they were making fewer errors.  
 The most valued endpoint of this study was the acceptance of the program by physicians. 
It was of concern that the physicians would feel threatened by pharmacy pointing out their errors. 
Through feedback survey results, the program was actually well received by all responders. 
Physicians actually expressed interest in more of their discharge medication lists being reviewed 
and on a more frequent basis. 
 Feedback from physicians is going to be used to create a much larger study potentially 
including 18 other institutions in England. Currently, the structure of who should provide 
feedback is being considered due to the physicians expressing preference that they would like to 
receive feedback from pharmacists. Also, seeing as antibacterial agents have the highest rates of 
error, more education may be focused towards these agents. 
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Feedback session structure 
 
Prior to session - email Dr informing them of date, time and location of feedback 
session ensuring location offers privacy with minimal disruption.  
 
Feedback session – questions to be covered 
 
• Have you looked through the discharge prescriptions that were issued to 
you? 
 
• Can you tell me what was good about that prescription? 
 
• Can you tell me what was bad or what could be improved? Explore Drs 
descriptions of errors they have identified covering: 
o The type of error made 
o The potential consequences of error 
o Reasons for the error 
 Elucidate whether slip/lapse vs. mistake (i.e. consciously the 
incorrect course of action was taken) 
o If have made the error before  
 
• Invite suggestions for improvement and prevention of error discussed 
 
• Offer own suggestions for improvement.  
 
• Possible error reducing strategies – discuss those pertinent to error 
discussed 
o Use of information sources, including other HCPs such as 
pharmacists, microbiology 
o Undertaking relevant learning – importance of keeping up-to-date 
o Self-checking processes and the importance of actively checking 
for errors  (particulars of prescription e.g. dose, route, formulation 
course length; side effects; interactions) 
o Identification of high risk patients 
Appendix 1 
o Identification of high risk drugs (corticosteroids, insulin, 
chemotherapy, anticoagulants, opiates , sedatives, penicillin 
allergy) 
o Time management 
o Improved communication and documentation  
o Use of IDS system 
 
• Discuss how to apply suggestions for improvement in practice and any 
perceived problems with strategies identified. 
 
• Complete for each error identified by Dr. 
 
• Discuss those errors not identified by Dr and repeat sections above. 
 
Conclusion 
Today we have discussed various prescribing errors, their causes and possible 
ways that they can be prevented.  
• From today’s discussion what changes do you now expect to make when 
prescribing? How and when? 
 
• Come to a decision on a list of mutually agreed goals from the session 
(may include tasks/goals for consultant). Record goals on paper.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Questionnaire 
 
Attitudes towards prescribing errors  
 
 
 
PLEASE RETURN IN THE FREEPOST ENVELOPE PROVIDED OR TO THE 
RESEARCH TEAM: 
 
[Insert name] FREEPOST MR9661, School of Pharmacy, The University of 
Manchester 
Oxford Road, Manchester M13 9HL. 
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Prescribing Errors  
 
We’re interested in learning about doctors’ perceptions of prescribing errors. 
Please answer the questions as best you can, remembering that your 
responses are entirely confidential 
 
For each question, please follow the instructions carefully and use a tick to indicate 
the option(s) you have selected or indicate your response on the appropriate lines. 
Feel free to write at the end of the questionnaire if you run out of space, but if you do, 
make sure you indicate which question you are referring to.   
 
 
1. How many prescribing errors of any kind do you think you have you made in the 
last week?    
  
 
 
 
 
  
 
2. How many minor prescribing errors do you think you have you made in the past 
week? 
 
 
 
 
 
   
 
3. How many serious prescribing errors do you think you have you made in the past 
week? 
   
 
 
 
 
 
4. Who was the last person to point out a prescribing error that you had made? 
(Other than the consultant during the feedback session) 
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5. What do you think constitutes a prescribing error (please tick all that apply) 
 
 
Ti
ck
 h
er
e 
if 
yo
u 
th
in
k 
th
is
 
co
ns
tit
ut
es
 
a pr
es
cr
ib
in
g 
er
ro
r  
Overdose   
Under-dose  
Incorrect route   
Omitted dose   
Omitted route  
Omission of a medication on admission  
Omission of a medication during patient stay or on discharge  
Omission of a medication on discharge  
Premature discontinuation  
Drug not prescribed but indicated  
Continuation for longer than needed  
No indication  
Significant allergy   
Clinical contra-indication  
Duplication of therapy  
Drug interaction  
No maximum dose   
Dose/rate mismatch  
No dosage alteration after levels out of range  
Incorrect formulation   
Incorrect administration times incorrect/missing  
administration times missing  
Start date incorrect  
Start date missing  
Product/formulation not specified  
Strength/dose missing  
No signature  
Requirements for controlled drug prescriptions (e.g. morphine) incorrect or 
missing  
 
Prescribing a branded medication  
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6. What do you do to reduce the chance of you making an error when prescribing? 
  
 
 
 
 
 
  
 
 
 
7. How do you know when a prescription you have written is safe? 
 
 
 
  
 
 
 
 
 
 
8. For EACH of the information sources shown in the table below, please indicate (with 
a tick) how often you would use the following sources of information to ensure a safe 
prescribing decision?   
 
 
Factors influencing your 
prescribing 
A
lw
ay
s 
of
te
n 
S
om
et
im
e
s N
ev
er
 
The BNF     
Clinical textbook      
Other text book      
NICE Guidelines     
Royal College guidance     
Hospital formulary / guidelines     
Accredited evidence based website e.g. 
Uptodate 
    
Non accredited website e.g. iphone app, 
Google, Wikipedia 
    
Senior doctor      
Peers     
Pharmacist      
Nurse     
Other (please specify)     
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9. For EACH statement given below, please indicate with a tick whether you agree or 
disagree with it.  
 
 
Statements  
S
tro
ng
ly
 a
gr
ee
 
A
gr
ee
 
N
ei
th
er
 a
gr
ee
 
or
 d
is
ag
re
e 
D
is
ag
re
e 
S
tro
ng
ly
 
di
sa
gr
ee
 
I make fewer errors now than when I first started working as a 
doctor 
 
     
Prescribing is less important than diagnosing  
 
     
Prescribing is a complex task 
 
     
Prescribing should be checked by a senior doctor? 
 
     
Knowing about all prescribing errors that I have made is 
important 
 
     
Knowing about all serious prescribing errors that I have made is 
important 
     
Knowing about all minor prescribing errors that I have made is 
important 
     
It is the job of the pharmacist to identify and correct all 
prescribing errors that I have made 
     
It is the job of the pharmacist to identify and correct all serious 
prescribing errors that I have made 
     
It is the job of the pharmacist to identify and correct all minor 
prescribing errors that I have made 
     
It is the job of the doctor to identify and correct all prescribing 
errors that he/she has made 
     
It is the job of the doctor to identify and correct all serious 
prescribing errors that he/she has made 
     
It is the job of the doctor to identify and correct all minor 
prescribing errors that he/she has made 
     
I would like the ward pharmacist to tell me about all prescribing 
errors that I have made 
     
I would like the ward pharmacist to tell me about all serious 
prescribing errors that I have made 
     
I would like the ward pharmacist to tell me about all minor 
prescribing errors that I have made 
     
I would like the consultant to tell me about all prescribing errors 
that I have made  
     
I would like the consultant to tell me about all serious prescribing 
errors that I have made 
     
I would like the consultant to tell me about all minor prescribing 
errors that I have made 
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10. For EACH statement given below please indicate the frequency that you think you 
demonstrate these behaviours when prescribing.  
 
 
Statements  
A
lw
ay
s 
M
os
t o
f t
he
 
tim
e 
O
cc
as
io
na
lly
  
R
ar
el
y 
N
ev
er
 
When prescribing, I have the all the information I need about the 
drug I am prescribing, including side effects and interactions 
     
When prescribing, I make sure I have all the information I need 
about the patient including co-morbidities and allergies   
     
When prescribing, I make sure I have taken an accurate drug 
history or have access to an accurate drug history   
     
I check computerised alerts for interactions and allergies 
 
     
I write prescriptions legibly with clear name and date 
 
     
I actively check my prescriptions for errors before signing them  
 
     
I follow up any prescribing that requires monitoring  
 
     
I work with the pharmacist when prescribing  
 
     
I convey details of my prescribing decisions to others in the team 
(either verbally or written) 
     
 
 
 
11.  Have you got anything to add about your opinions of prescribing errors or 
prescribing safely?  If you have, please tell us here. 
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 DEMOGRAPHIC DETAILS 
 
We have already taken these details from some of you when you filled in a 
consent form, but could you please provide us with the following basic 
information again for efficient administration purposes. This information will be 
stored in a way that preserves your anonymity and the confidentiality of 
answers you have given.  Thank you. 
 
 
 
Your full name: 
 
 
Your date of birth: 
 
 
Your job title: 
 
 
Your gender:  
 
1 Male 
2  Female 
 
    
 
 
 
Thank you very much for taking the time to complete this questionnaire. Please place 
in the sealed envelope and return it to the members of the study team here today, or 
by FREEPOST to: 
 
[insert name] School of Pharmacy, FREEPOST MR9661, The University of 
Manchester, Oxford Road, Manchester.  M13 9HL 
ID No: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Questionnaire 
 
Feedback Evaluation 
 
 
 
PLEASE RETURN IN THE FREEPOST ENVELOPE PROVIDED OR TO THE 
RESEARCH TEAM: 
 
[Insert name] FREEPOST MR9661, School of Pharmacy, The University of 
Manchester 
Oxford Road, Manchester M13 9HL. 
 
Appendix 3 
 Feedback Evaluation Questionnaire. Page 2 
 
 
 
 
We’re interested in your thoughts about the feedback process and how you felt 
it went. Please answer the questions as best you can, remembering that all 
responses are confidential.  
 
 
For each question, please follow the instructions carefully and complete your 
response on the dedicated lines or use a tick to indicate the option(s) you have 
selected .  After answering each question, go to the next one unless directed 
otherwise. 
 
1. What did you like most about the feedback sessions?   
 
 
 
 
 
 
 
   
 
2. What did you like least about the feedback sessions?    
 
 
 
 
 
 
 
 
 
3. What could have improved the experience of the feedback sessions?    
 
 
 
 
 
 
 
 
 
4. Would you recommend these feedback sessions to colleagues? 
 
1 Yes   
2 No 
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5. How did you find the timing of the feedback session in relation to the identified 
errors? 
 
 
 
 
 
 
 
 
 
6. Were you happy with pharmacists collecting these data about your errors?  
 
1 Yes  Please go to question 7.     
2 No    Please go to question 6. 
 
 
 
7. If you answered ‘No’ to the previous question, please state why? 
 
 
 
 
 
 
 
 
 
8. Rank in order from 1-5 (5 = most preferred, 1= least preferred) the profession you 
would most like to deliver the feedback sessions.  Use each number only once. 
 
 
 
 
 
 
 
 
 
 
 
 
 
9. Do you think this experience has changed your current practice? 
 
1 Yes  Please go to question 10.     
2 No    Please go to question 11. 
 
 
 
 
10. If yes, describe how? (please tick all that apply)  
 
Professional group  
R
an
k 
or
de
r 
Registrars       
Consultants     
Pharmacists  
Peers     
Nurses     
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1  Sought advice when prescribing from a pharmacist 
2  Sought advice when prescribing from another doctor 
3  Used references when prescribing  
4  Avoided prescribing where possible  
5  Double checked my prescribing 
6 Other (please specify below) 
 
 
 
 
11. If no, describe why this experience hasn’t changed your practice 
 
 
 
 
 
 
 
 
 
12. For EACH of the statements shown in the table below, please indicate with a tick 
how strongly you agree or disagree. 
 
 
 
 
12.  Have you got anything to add about how you found the feedback process?  If you 
have, please tell us here. 
 
Statements  
S
tro
ng
ly
 
ag
re
e 
A
gr
ee
 
N
ei
th
er
 
ag
re
e 
or
 
di
sa
gr
ee
 
D
is
ag
re
e 
S
tro
ng
ly
 
di
sa
gr
ee
 
The feedback session made me feel nervous/anxious 
beforehand 
 
     
The feedback session was a positive event  at the time 
 
     
I found the session motivating   
 
     
I would not want to take part in another feedback session 
 
     
Feedback on prescribing errors should be provided in 
written format as well as verbally 
     
I am concerned about the confidentiality of this feedback 
process 
     
Feedback on prescribing errors  should be provided a 
regular basis  
 
     
Feedback should be provided on all types of prescriptions 
(inpatient, outpatient) 
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DEMOGRAPHIC DETAILS 
 
We have already taken these details from some of you when you filled in a 
consent form, but could you please provide us with the following basic 
information again for efficient administration purposes. This information will be 
stored in a way that preserves your anonymity and the confidentiality of 
answers you have given.  Thank you. 
 
 
 
Your name: 
 
 
Your date of birth: 
 
 
Your job title: 
 
 
Your gender:  
 
1 Male 
2  Female 
 
   
Thank you very much for taking the time to complete this questionnaire. Please 
return it to the members of the study team here today, or by FREEPOST to: 
[insert name], School of Pharmacy, FREEPOST MR9661, The University of 
Manchester, Oxford Road, Manchester.  M13 9HL 
ID No: 
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Table 1. Type of Error 
Omission on admission 
Omission on rewrite 
Omission on discharge medication list 
Premature discontinuation 
Drug not prescribed but indicated 
Continuation for longer than needed 
No indication 
Duplication 
Significant allergy 
Clinical contraindication 
Continuation after adverse drug reaction (ADR) 
Drug Interaction 
Unintentional prescription of drug 
No maximum dose 
Drug interaction not taken into account 
Dose/rate mismatch 
No dosage alteration after levels out of range 
Daily dose divided incorrectly 
Overdose 
Underdose 
Incorrect Route 
Incorrect Formulation 
Administration times incorrect/missing 
IV instructions incorrect/missing 
Start date incorrect/missing 
Product/formulation not specified 
Strength/dose missing 
Route missing 
No signature 
No communication about medicine changes 
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Potentially lethal 
error1 
 
An error is defined as potentially lethal if it could have one or more of the following consequences: 
 The serum level resulting form such a dose is likely to be in the severe toxicity range based on common dosage guidelines, e.g. 
serum theophylline concentrations greater than 30 micrograms per ml. More than 10 times the dose of chemotherapy agent 
 The drug being administered has a high potential to cause cardiopulmonary arrest in the dose ordered.  
 The drug being administered has a high potential to cause a life threatening adverse reaction, such as anaphylaxis, in light of the 
patient’s medical history. 
 The dose of a potentially life saving drug is too low for a patient having the disease being treated 
 The dose of a drug with a very low therapeutic index is too high (ten times the normal dose)  
Serious error2 
 
An error is defined as serious if it could have one or more of the following results: 
 The route of drug administration ordered is inappropriate, with the potential of causing the patient to suffer a severe toxic reaction.  
 The dose of the drug prescribed is too low for a patient with serious disease who is in acute distress 
 The dose of a drug with a low therapeutic index is too high (four to ten times the normal dose)  
 The dose of the drug would result in serum drug levels in the toxic range, e.g. theophylline levels 20-30 micrograms per mL.  
 The drug orders could exacerbate the patient’s condition, e.g. drug-drug interaction or drug-disease interaction. 
 The name of the drug is misspelled or illegible creating a risk that the wrong drug might be dispensed including errors in decimal 
points or units if the error could lead to the dose being given  
 High dosage (ten times) normal of a drug without a low therapeutic index  
Significant error1 
 
An error is defined as significant if it could have one or more of the following results: 
 The dose of the drug with low therapeutic index is too high (half – four times the normal dose)  
 The dose of the drug is too low for a patient with the condition being treated  
 The wrong laboratory studies to monitor a specific side effect of a drug are ordered e.g. CBC and reticulocyte counts are ordered to 
monitor gentamicin toxicity 
 The wrong route of administration for the condition being treated is ordered e.g. the inadvertent change from IV to oral therapy for the 
Appendix D 
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treatment of bacterial  
 meningitis.  
 Errors ordering fluids are made e.g. specific additives needed for complete therapy are omitted or incompatible fluids are ordered 
 Errors of omission whereby patient’s regular medication is not prescribed either on admission, during a rewrite and on discharge  
Minor error 2,3,4,5 
 
An error is defined as minor if it could have one or more of the following results: 
 Duplicate therapy was prescribed without potential for increased adverse effects 
 The wrong route was ordered without potential for toxic reactions or therapeutic failure 
 The order lacked specific drug, dose, dosage strength, frequency, route or frequency information 
 Illegible, ambiguous or non-standard abbreviations   
 An errant order was written that was unlikely to be carried out given the nature of the drug, dosage forms, route ordered, missing 
information etc 
Examples include, simvastatin prescribed in the morning rather than at night. Bisoprolol – two puffs four times a day. 
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Classes of medications where prescribing errors were made 
• Antisecretory drugs and mucosal protectants  
• Laxitivies 
• Lipid regulating drugs 
• Hypertension and heart failure drugs  
• Nitrates  
• Calcium channel blockers and antianginal drugs 
• Bronchodilators  
• Inhaled corticosteroids 
• Hypnotics and anxiolytics  
• Drugs used in psychosis 
• Antidepressants  
• Drugs used in nausea and vertigo 
• Analgesics 
• Antiepileptics  
• Antibacterial drugs, 
• Corticosteroids  
• Drugs affecting bone metabolism  
• Drugs affecting immune response 
• Drugs for anemia and other blood disorders 
• Fluids and electrolytes 
• Vitamins 
• Ophthalmic preparations 
• Emollient and barrier protectant preparations  
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